1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Virus-like Particles Market – By Product Type

1.3.2        Asia Pacific Virus-like Particles Market – By Source

1.3.3        Asia Pacific Virus-like Particles Market – By Application

1.3.4        Asia Pacific Virus-like Particles Market – By Country

2.           Asia Pacific Virus-like Particles Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Virus-like Particles Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Experts Opinion

5.           Asia Pacific Virus-like Particles Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Surging Prevalence of Infectious Viral Diseases

5.1.2        Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2         Market Restraints

5.2.1        Reach of Alternative Technologies for Viral Vaccine Production

5.3         Market Opportunities

5.3.1        Growing Potential Applications in Therapeutics and Diagnostics

5.4         Future Trends

5.4.1        Steady Demand for Innovative and Effective Products

5.5         Impact Analysis

6.           Asia Pacific Virus-like Particles Market Analysis

6.1         Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis

7.           Asia Pacific Virus-like Particles Market Analysis – by Product Type

7.1         Overview

7.2         Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3         Hepatitis

7.3.1        Overview

7.3.2        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4         Cancer/ Human Papillomavirus (HPV)

7.4.1        Overview

7.4.2        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5         Gaucher Disease

7.5.1        Overview

7.5.2        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.           Asia Pacific Virus-like Particles Market Analysis – By Source

8.1         Overview

8.2         Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3         Yeast

8.3.1        Overview

8.3.2        Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4         Plant

8.4.1        Overview

8.4.2        Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5         Insect Cell

8.5.1        Overview

8.5.2        Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6         Others

8.6.1        Overview

8.6.2        Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.           Asia Pacific Virus-like Particles Market Analysis – By Application

9.1         Overview

9.2         Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3         Vaccines

9.3.1        Overview

9.3.2        Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4         Therapeutics

9.4.1        Overview

9.4.2        Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.        Asia Pacific Virus-like Particles Market – Country Analysis

10.1      Overview

10.1.1     Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1       Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1       Overview

10.1.1.1.2       Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3       Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

10.1.1.1.4       Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.1.5       Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2       China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1       Overview

10.1.1.2.2       China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3       China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4       China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.2.5       China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3       India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1       Overview

10.1.1.3.2       India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3       India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4       India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5       India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4       South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1       Overview

10.1.1.4.2       South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3       South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4       South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5       South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5       Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1       Overview

10.1.1.5.2       Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3       Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4       Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5       Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6       Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3       Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4       Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5       Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11.        Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market

11.1      Impact Assessment of COVID-19 Pandemic

12.        Asia Pacific Virus-like Particles Market–Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.        Company Profiles

13.1      Merck & Co., Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      GlaxoSmithKline plc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Pfizer Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Sanofi

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Wantai BioPharm

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Serum Institute of India Pvt. Ltd.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      BHARAT BIOTECH

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      LG Chem

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2.             Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 3.             Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 4.             Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5.             China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6.             China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 7.             China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8.             India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 9.             India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10.          India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11.          South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12.          South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13.          South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14.          Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 15.          Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 16.          Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17.          Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 18.          Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 19.          Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20.          Organic Developments Done by Companies

Table 21.          Inorganic Developments Done by Companies

Table 22.          Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1.           Asia Pacific Virus-like particles Market Segmentation

Figure 2.           Asia Pacific Virus-like particles Market Segmentation, By Country

Figure 3.           Asia Pacific Virus-like Particles Market Overview

Figure 4.           Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market

Figure 5.           India to Show Significant Growth during Forecast Period

Figure 6.           Asia Pacific Virus-like Particles Market, Industry Landscape

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9.           Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10.        Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11.        Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15.        Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20.        Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Asia Pacific Virus-like Particles Market Overview, by Country (2021)

Figure 23.        Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24.        Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25.        China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27.        South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets